Latest filing published 02 Mar 2021 for Amneal Pharmaceuticals, Inc., €26k.
Insider track record
No signal scores available.
Stephen Manzano: trading record in brief
Stephen Manzano discloses dealings in Amneal Pharmaceuticals, Inc. to SEC (Form 4). In total, 2 filings cover trades dated 27 February 2021.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 2 March 2021, the filings show a share grant worth €26k in Amneal Pharmaceuticals, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Stephen Manzano
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,796 shares@ US$5.39100.0% of flowClass A Common StockSEC:0001209191-21-016046:1
- 16,490 sharesClass A Common StockSEC:0001209191-21-016046:0
2 of 2 declarations
